Adrenocortical carcinoma (ACC) is a rare, aggressive malignancy with an annual incidence
of~ 1 case per million population. Differentiating between ACC and benign adrenocortical …

Adrenocortical carcinoma (ACC) is a rare and in most cases steroid hormone-producing
tumor with variable prognosis. The purpose of these guidelines is to provide clinicians with …

Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis, the five-years
overall survival being below 40%. However, there is great variability of outcomes and we …

Context Adrenocortical carcinoma (ACC) has a heterogeneous prognosis, and current
medical therapies have limited efficacy in its advanced stages. Genome-wide multiomics …

Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with high risk of
recurrence despite macroscopically complete surgical resection. The main predictors of …

Background Open adrenalectomy is considered a standard operative approach for
adrenocortical carcinoma, and laparoscopic adrenalectomy remains controversial. We …

Adrenocortical carcinomas (ACCs) are rare and aggressive malignancies of adrenal cortex,
associated with largely unknown mechanisms of biological development and poor …

Background Laparoscopic surgery is considered a standard treatment for benign adrenal
tumors; however, no consensus has been reached on the optimal resection technique for …

Adrenocortical carcinoma (ACC) is a rare malignancy that is frequently asymptomatic at
presentation, yet has a high rate of metastatic disease at the time of diagnosis. Prognosis is …

Purpose Adrenocortical carcinoma (ACC) is an aggressive tumor characterized by a high
recurrence rate and poor response to treatment. This study analyzes a consecutive series of …